{"id":"https://openalex.org/W4283582857","doi":"https://doi.org/10.1186/s12933-022-01555-z","title":"Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)","display_name":"Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)","publication_year":2022,"publication_date":"2022-06-27","ids":{"openalex":"https://openalex.org/W4283582857","doi":"https://doi.org/10.1186/s12933-022-01555-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/35761271","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9238154"},"language":"en","primary_location":{"id":"doi:10.1186/s12933-022-01555-z","doi":"https://doi.org/10.1186/s12933-022-01555-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-022-01555-z","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-022-01555-z","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-022-01555-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043791621","display_name":"Timothy M. E. Davis","orcid":"https://orcid.org/0000-0003-0749-7411","observed_orcids":["https://orcid.org/0000-0003-0749-7411"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2802692842","display_name":"Fremantle Hospital","ror":"https://ror.org/03yxgmm62","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802692842","https://openalex.org/I4388446375","https://openalex.org/I4388482742"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Timothy M. E. Davis","raw_affiliation_strings":["Medical School, University of Western Australia, Fremantle Hospital, P.O. Box 480, Fremantle, WA, Australia. tim.davis@uwa.edu.au","Medical School, University of Western Australia, Fremantle Hospital, P.O. Box 480, Fremantle, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical School, University of Western Australia, Fremantle Hospital, P.O. Box 480, Fremantle, WA, Australia. tim.davis@uwa.edu.au","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802692842"]},{"raw_affiliation_string":"Medical School, University of Western Australia, Fremantle Hospital, P.O. Box 480, Fremantle, WA, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802692842"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075229234","display_name":"Anna Giczewska","orcid":"https://orcid.org/0000-0003-0533-2453","observed_orcids":["https://orcid.org/0000-0003-0533-2453"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Giczewska","raw_affiliation_strings":["Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107918445","display_name":"Yuliya V. Lokhnygina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuliya Lokhnygina","raw_affiliation_strings":["Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068642565","display_name":"Robert John Mentz","orcid":"https://orcid.org/0000-0002-3222-1719","observed_orcids":["https://orcid.org/0000-0002-3222-1719"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Mentz","raw_affiliation_strings":["Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078498803","display_name":"Naveed A. Sattar","orcid":"https://orcid.org/0000-0002-1604-2593","observed_orcids":["https://orcid.org/0000-0002-1604-2593"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Naveed Sattar","raw_affiliation_strings":["Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049740900","display_name":"Rury R. Holman","orcid":"https://orcid.org/0000-0002-1256-874X","observed_orcids":["https://orcid.org/0000-0002-1256-874X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rury R. Holman","raw_affiliation_strings":["Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the EXSCEL Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the EXSCEL Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5043791621"],"corresponding_institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802692842"],"apc_list":{"value":3590,"currency":"USD","value_usd":3590},"apc_paid":{"value":3590,"currency":"USD","value_usd":3590},"fwci":1.0637,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.75659727,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"21","issue":"1","first_page":"116","last_page":"116"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8009999990463257},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cardiometabolic-responses","display_name":"cardiometabolic responses","score":0.8790000081062317},{"id":"https://openalex.org/keywords/exscel-trial","display_name":"EXSCEL trial","score":0.8650000095367432},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7519999742507935},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.47600001096725464},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.9290000200271606},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.7329999804496765},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9769999980926514},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.984000027179718},{"id":"https://openalex.org/keywords/resting-heart-rate","display_name":"resting heart rate","score":0.828000009059906},{"id":"https://openalex.org/keywords/asian-participants","display_name":"Asian participants","score":0.6769999861717224},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.828000009059906},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.7139999866485596},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.31299999356269836}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9833329916000366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8638709783554077},{"id":"https://openalex.org/C3018127138","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Cardiovascular event","level":3,"score":0.6143483519554138},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.527419924736023},{"id":"https://openalex.org/C76509639","wikidata":"https://www.wikidata.org/wiki/Q918036","display_name":"Race (biology)","level":2,"score":0.5208585858345032},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5062398314476013},{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.4420850872993469},{"id":"https://openalex.org/C555175668","wikidata":"https://www.wikidata.org/wiki/Q539690","display_name":"Angiology","level":2,"score":0.431057870388031},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.41538187861442566},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36367228627204895},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.14010652899742126},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1186/s12933-022-01555-z","doi":"https://doi.org/10.1186/s12933-022-01555-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-022-01555-z","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-022-01555-z","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9238154","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9238154","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Diabetol","raw_type":"Text"},{"id":"pmid:35761271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35761271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular diabetology","raw_type":"Journal Article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:956048f8-82ae-4a93-b3c7-1ec8ed4e5162","doi":null,"is_oa":false,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:956048f8-82ae-4a93-b3c7-1ec8ed4e5162/files/r6h440v91s","pdf_url":null,"source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OpenAlex","raw_type":"Journal article"},{"id":"pmh:oai:eprints.gla.ac.uk:274065","doi":null,"is_oa":true,"landing_page_url":"http://eprints.gla.ac.uk/274065/1/274065.pdf","pdf_url":"http://eprints.gla.ac.uk/274065/1/274065.pdf","source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Articles"},{"id":"pmh:oai:pure.atira.dk:openaire/8b25e803-1dd0-4d39-9990-778f498436aa","doi":null,"is_oa":true,"landing_page_url":"https://research-repository.uwa.edu.au/en/publications/8b25e803-1dd0-4d39-9990-778f498436aa","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2022, 'Effect of race on cardiometabolic responses to once-weekly exenatide : insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)', Cardiovascular Diabetology, vol. 21, no. 1, 116. https://doi.org/10.1186/s12933-022-01555-z","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:c1b10a2baf864e11b58ac17fccdefab3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c1b10a2baf864e11b58ac17fccdefab3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-9 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12933-022-01555-z","doi":"https://doi.org/10.1186/s12933-022-01555-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-022-01555-z","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-022-01555-z","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320337533","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/00py81415"},{"id":"https://openalex.org/F4906014721","display_name":"Medical Research Future Fund","ror":"https://ror.org/0513v5k17"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283582857.pdf","grobid_xml":"https://content.openalex.org/works/W4283582857.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1887330886","https://openalex.org/W2018666069","https://openalex.org/W2034667874","https://openalex.org/W2040794084","https://openalex.org/W2052335770","https://openalex.org/W2062618262","https://openalex.org/W2063788890","https://openalex.org/W2114596436","https://openalex.org/W2115625546","https://openalex.org/W2137188649","https://openalex.org/W2138077952","https://openalex.org/W2141917858","https://openalex.org/W2142979505","https://openalex.org/W2147708693","https://openalex.org/W2200208573","https://openalex.org/W2234515934","https://openalex.org/W2265195502","https://openalex.org/W2475233216","https://openalex.org/W2576609254","https://openalex.org/W2588615098","https://openalex.org/W2621170816","https://openalex.org/W2754041380","https://openalex.org/W2789175291","https://openalex.org/W2894993577","https://openalex.org/W2907390276","https://openalex.org/W2929699772","https://openalex.org/W2979558564","https://openalex.org/W2980685606","https://openalex.org/W2992821646","https://openalex.org/W3011492655","https://openalex.org/W3042485772","https://openalex.org/W3093042356","https://openalex.org/W3118067039","https://openalex.org/W3126770844","https://openalex.org/W3161422101","https://openalex.org/W4252795044","https://openalex.org/W4253996779"],"related_works":["https://openalex.org/W6939673742","https://openalex.org/W4413446625","https://openalex.org/W2788743231","https://openalex.org/W2139377033","https://openalex.org/W2788478511","https://openalex.org/W3120630671","https://openalex.org/W7084048533","https://openalex.org/W4298189250","https://openalex.org/W2158290990","https://openalex.org/W2888943767"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"determine":[2],"whether":[3],"there":[4],"were":[5,36,47,93,101,175,239],"racial":[6,179,244],"differences":[7],"in":[8,16,61,90,103,123,140,177,204,209,241,246,255],"short-term":[9],"cardiometabolic":[10,91,235],"responses":[11,236],"to":[12,39,110,143,149,158,164,172,237],"once-weekly":[13],"exenatide":[14],"(EQW)":[15],"the":[17,104,178,242],"Exenatide":[18],"Study":[19],"of":[20,58,194,228],"Cardiovascular":[21],"Event":[22],"Lowering":[23],"(EXSCEL).":[24],"METHODS:":[25],")":[26],"6.5-10.0%":[27],"[48-86":[28],"mmol/mol])":[29],"with":[30,119,196,230],"or":[31,41,79],"without":[32],"cardiovascular":[33,45],"disease":[34],"who":[35],"randomized":[37],"double-blind":[38],"EQW":[40,238],"placebo.":[42],"Background":[43],"glucose-lowering/other":[44],"therapies":[46],"unaltered":[48],"for":[49,116,184,192,218,226],"6":[50,86],"months":[51],"post-randomization":[52],"unless":[53],"clinically":[54],"essential,":[55],"facilitating":[56],"comparison":[57],"EQW-associated":[59],"effects":[60],"14,665":[62],"evaluable":[63],"participants":[64],"self-identifying":[65],"as":[66],"White":[67],"(n":[68,72,76,82],"=":[69,73,77,83,114,216],"11,113),":[70],"Asian":[71],"1444),":[74],"Black":[75],"870),":[78],"Other":[80],"Race":[81],"1,238.":[84],"Placebo-adjusted":[85],"month":[87],"absolute":[88],"changes":[89,139],"variables":[92],"assessed":[94],"using":[95],"generalized":[96],"linear":[97],"models.":[98],"RESULTS:":[99],"reductions":[100],"similar":[102,176,240],"four":[105],"groups":[106,128,180,211,245],"(range":[107],"0.54-0.67%":[108],"[5.9":[109],"7.3":[111],"mmol/mol],":[112],"P":[113,133,189,215,223],"0.11":[115],"race\u00d7treatment":[117,185,219],"interaction),":[118],"no":[120],"significant":[121],"difference":[122],"Asians":[124,195,205,229],"(reference)":[125],"versus":[126],"other":[127,197,210,231],"after":[129],"covariate":[130],"adjustment":[131],"(all":[132],"\u2265":[134,182,190],"0.10).":[135],"Six-month":[136],"placebo-adjusted":[137],"mean":[138],"systolic":[141],"(-1.8":[142],"0.0":[144,173],"mmHg)":[145,151],"and":[146,161,168,187,221],"diastolic":[147],"(0.2":[148],"1.2":[150],"blood":[152],"pressure,":[153],"serum":[154,169],"LDL":[155],"(-":[156],"0.06":[157],"0.02":[159],"mmol/L)":[160,166,174],"HDL":[162],"(0.00":[163],"0.01":[165],"cholesterol,":[167],"triglycerides":[170],"(-0.1":[171],"(P":[181],"0.19":[183],"interaction":[186,220],"all":[188,222],"0.13":[191],"comparisons":[193,227],"races).":[198,232],"Resting":[199],"pulse":[200,252],"rate":[201,253],"increased":[202],"more":[203],"(4":[206],"beats/min)":[207],"than":[208],"(\u2264":[212],"3":[213],"beats/min,":[214],"0.016":[217],"\u2264":[224],"0.050":[225],"CONCLUSIONS:":[233],"Short-term":[234],"main":[243],"EXSCEL,":[247],"apart":[248],"from":[249],"a":[250],"greater":[251],"increase":[254],"Asians.":[256],"TRIAL":[257],"REGISTRATION:":[258],"https://clinicaltrials.gov":[259],"NCT01144338.":[260]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-28T00:00:00"}